BACKGROUND: Throughout the 2014-2015 Ebola outbreak in West Africa, major gaps were exposed in the availability of validated rapid diagnostic platforms, protective vaccines, and effective therapeutic agents. These gaps potentiated the development of prototype rapid lateral flow immunodiagnostic (LFI) assays that are true point-of-contact platforms, for the detection of active Ebola infections in small blood samples. METHODS: Recombinant Ebola and Marburg virus matrix VP40 and glycoprotein (GP) antigens were used to derive a panel of monoclonal and polyclonal antibodies. Antibodies were tested using a multivariate approach to identify antibody-antigen combinations suitable for enzyme-linked immunosorbent assay (ELISA) and LFI assay development. RESULTS: Polyclonal antibodies generated in goats were superior reagents for capture and detection of recombinant VP40 in test sample matrices. These antibodies were optimized for use in antigen-capture ELISA and LFI assay platforms. Prototype immunoglobulin M (IgM)/immunoglobulin G (IgG) ELISAs were similarly developed that specifically detect Ebola virus-specific antibodies in the serum of experimentally infected nonhuman primates and in blood samples obtained from patients with Ebola from Sierra Leone. CONCLUSIONS: The prototype recombinant Ebola LFI assays developed in these studies have sensitivities that are useful for clinical diagnosis of acute ebolavirus infections. The antigen-capture and IgM/IgG ELISAs provide additional confirmatory assay platforms for detecting VP40 and other ebolavirus-specific immunoglobulins.
BACKGROUND: Throughout the 2014-2015 Ebola outbreak in West Africa, major gaps were exposed in the availability of validated rapid diagnostic platforms, protective vaccines, and effective therapeutic agents. These gaps potentiated the development of prototype rapid lateral flow immunodiagnostic (LFI) assays that are true point-of-contact platforms, for the detection of active Ebola infections in small blood samples. METHODS: Recombinant Ebola and Marburg virus matrix VP40 and glycoprotein (GP) antigens were used to derive a panel of monoclonal and polyclonal antibodies. Antibodies were tested using a multivariate approach to identify antibody-antigen combinations suitable for enzyme-linked immunosorbent assay (ELISA) and LFI assay development. RESULTS: Polyclonal antibodies generated in goats were superior reagents for capture and detection of recombinant VP40 in test sample matrices. These antibodies were optimized for use in antigen-capture ELISA and LFI assay platforms. Prototype immunoglobulin M (IgM)/immunoglobulin G (IgG) ELISAs were similarly developed that specifically detect Ebola virus-specific antibodies in the serum of experimentally infected nonhuman primates and in blood samples obtained from patients with Ebola from Sierra Leone. CONCLUSIONS: The prototype recombinant Ebola LFI assays developed in these studies have sensitivities that are useful for clinical diagnosis of acute ebolavirus infections. The antigen-capture and IgM/IgG ELISAs provide additional confirmatory assay platforms for detecting VP40 and other ebolavirus-specific immunoglobulins.
Authors: John S Schieffelin; Jeffrey G Shaffer; Augustine Goba; Michael Gbakie; Stephen K Gire; Andres Colubri; Rachel S G Sealfon; Lansana Kanneh; Alex Moigboi; Mambu Momoh; Mohammed Fullah; Lina M Moses; Bethany L Brown; Kristian G Andersen; Sarah Winnicki; Stephen F Schaffner; Daniel J Park; Nathan L Yozwiak; Pan-Pan Jiang; David Kargbo; Simbirie Jalloh; Mbalu Fonnie; Vandi Sinnah; Issa French; Alice Kovoma; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Josephine Sellu; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Sidiki Saffa; James L B Massally; Matt L Boisen; Luis M Branco; Mohamed A Vandi; Donald S Grant; Christian Happi; Sahr M Gevao; Thomas E Fletcher; Robert A Fowler; Daniel G Bausch; Pardis C Sabeti; S Humarr Khan; Robert F Garry Journal: N Engl J Med Date: 2014-10-29 Impact factor: 91.245
Authors: Robert A Fowler; Thomas Fletcher; William A Fischer; Francois Lamontagne; Shevin Jacob; David Brett-Major; James V Lawler; Frederique A Jacquerioz; Catherine Houlihan; Tim O'Dempsey; Mauricio Ferri; Takuya Adachi; Marie-Claire Lamah; Elhadj Ibrahima Bah; Thierry Mayet; John Schieffelin; Susan L McLellan; Mikiko Senga; Yasuyuki Kato; Christophe Clement; Simon Mardel; Rosa Constanza Vallenas Bejar De Villar; Nahoko Shindo; Daniel Bausch Journal: Am J Respir Crit Care Med Date: 2014-10-01 Impact factor: 21.405
Authors: Luis M Branco; Matt L Boisen; Kristian G Andersen; Jessica N Grove; Lina M Moses; Ivana J Muncy; Lee A Henderson; John S Schieffellin; James E Robinson; James J Bangura; Donald S Grant; Vanessa N Raabe; Mbalu Fonnie; Eleina M Zaitsev; Pardis C Sabeti; Robert F Garry Journal: Virol J Date: 2011-08-15 Impact factor: 4.099
Authors: Luis M Branco; Jessica N Grove; Matt L Boisen; Jeffrey G Shaffer; Augustine Goba; Mohammed Fullah; Mambu Momoh; Donald S Grant; Robert F Garry Journal: Virol J Date: 2011-10-24 Impact factor: 4.099
Authors: Jeffrey G Shaffer; Donald S Grant; John S Schieffelin; Matt L Boisen; Augustine Goba; Jessica N Hartnett; Danielle C Levy; Rachael E Yenni; Lina M Moses; Mohammed Fullah; Mambo Momoh; Mbalu Fonnie; Richard Fonnie; Lansana Kanneh; Veronica J Koroma; Kandeh Kargbo; Darin Ottomassathien; Ivana J Muncy; Abigail B Jones; Megan M Illick; Peter C Kulakosky; Allyson M Haislip; Christopher M Bishop; Deborah H Elliot; Bethany L Brown; Hu Zhu; Kathryn M Hastie; Kristian G Andersen; Stephen K Gire; Shervin Tabrizi; Ridhi Tariyal; Mathew Stremlau; Alex Matschiner; Darryl B Sampey; Jennifer S Spence; Robert W Cross; Joan B Geisbert; Onikepe A Folarin; Christian T Happi; Kelly R Pitts; F Jon Geske; Thomas W Geisbert; Erica Ollmann Saphire; James E Robinson; Russell B Wilson; Pardis C Sabeti; Lee A Henderson; S Humarr Khan; Daniel G Bausch; Luis M Branco; Robert F Garry Journal: PLoS Negl Trop Dis Date: 2014-03-20
Authors: Stephen K Gire; Augustine Goba; Kristian G Andersen; Rachel S G Sealfon; Daniel J Park; Lansana Kanneh; Simbirie Jalloh; Mambu Momoh; Mohamed Fullah; Gytis Dudas; Shirlee Wohl; Lina M Moses; Nathan L Yozwiak; Sarah Winnicki; Christian B Matranga; Christine M Malboeuf; James Qu; Adrianne D Gladden; Stephen F Schaffner; Xiao Yang; Pan-Pan Jiang; Mahan Nekoui; Andres Colubri; Moinya Ruth Coomber; Mbalu Fonnie; Alex Moigboi; Michael Gbakie; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Sidiki Saffa; Josephine Sellu; Abdul Azziz Jalloh; Alice Kovoma; James Koninga; Ibrahim Mustapha; Kandeh Kargbo; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Willie Robert; James L B Massally; Sinéad B Chapman; James Bochicchio; Cheryl Murphy; Chad Nusbaum; Sarah Young; Bruce W Birren; Donald S Grant; John S Scheiffelin; Eric S Lander; Christian Happi; Sahr M Gevao; Andreas Gnirke; Andrew Rambaut; Robert F Garry; S Humarr Khan; Pardis C Sabeti Journal: Science Date: 2014-08-28 Impact factor: 47.728
Authors: Robert W Cross; Matthew L Boisen; Molly M Millett; Diana S Nelson; Darin Oottamasathien; Jessica N Hartnett; Abigal B Jones; Augustine Goba; Mambu Momoh; Mohamed Fullah; Zachary A Bornholdt; Marnie L Fusco; Dafna M Abelson; Shunichiro Oda; Bethany L Brown; Ha Pham; Megan M Rowland; Krystle N Agans; Joan B Geisbert; Megan L Heinrich; Peter C Kulakosky; Jeffrey G Shaffer; John S Schieffelin; Brima Kargbo; Momoh Gbetuwa; Sahr M Gevao; Russell B Wilson; Erica Ollmann Saphire; Kelly R Pitts; Sheik Humarr Khan; Donald S Grant; Thomas W Geisbert; Luis M Branco; Robert F Garry Journal: J Infect Dis Date: 2016-08-31 Impact factor: 5.226
Authors: Mohan Natesan; Sz-Wei Wu; Chieh-I Chen; Stig M R Jensen; Neven Karlovac; Beverly K Dyas; Onur Mudanyali; Robert G Ulrich Journal: ACS Sens Date: 2018-12-28 Impact factor: 7.711
Authors: Brandon J Beddingfield; Jessica N Hartnett; Russell B Wilson; Peter C Kulakosky; Kristian G Andersen; Refugio Robles-Sikisaka; Nathan D Grubaugh; Argelia Aybar; Maria-Zunilla Nunez; Cesar D Fermin; Robert F Garry Journal: Viruses Date: 2021-09-05 Impact factor: 5.048